{
    "id": 30249,
    "fullName": "GOLGA4 - RAF1",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "GOLGA4-RAF1 results in a fusion with GOLGA4 and RAF1, which results in increased cell proliferation in culture and elevated MAPK signaling, as indicated by Erk phosphorylation (PMID: 30835257). GOLGA4-RAF1 has been identified in melanoma (PMID: 30835257).",
            "references": [
                {
                    "id": 15243,
                    "pubMedId": 30835257,
                    "title": "Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30835257"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2803,
        "geneSymbol": "GOLGA4",
        "terms": [
            "GOLGA4",
            "CRPF46",
            "GCP2",
            "GOLG",
            "MU-RMS-40.18",
            "p230"
        ]
    },
    "variant": "GOLGA4 - RAF1",
    "createDate": "06/03/2019",
    "updateDate": "06/03/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 5894,
                "geneSymbol": "RAF1",
                "terms": [
                    "RAF1",
                    "c-Raf",
                    "CMD1NN",
                    "CRAF",
                    "NS5",
                    "Raf-1"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 17248,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a patient with metastatic melanoma harboring GOLGA4-RAF1 was sensitive to treatment with Mekinist (trametinib), demonstrating a significant extracranial response (PMID: 30835257).",
            "molecularProfile": {
                "id": 32399,
                "profileName": "GOLGA4 - RAF1"
            },
            "therapy": {
                "id": 2,
                "therapyName": "Trametinib",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 15243,
                    "pubMedId": 30835257,
                    "title": "Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30835257"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 32399,
            "profileName": "GOLGA4 - RAF1",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}